Source comparison
MK-677 for Men 35-45: Comparison
MK-677 Ghrelin receptor agonist; stimulates endogenous GH pulses 40–90% increase at 12.5–25mg daily Water retention, increased appetite, mild glucose elevation Optimal for men seeking GH optimization without axis suppression or injection requirement Best first
This comparison does not assign a generated winner or score.
- MK-677
- Ghrelin receptor agonist; stimulates endogenous GH pulses
- 40–90% increase at 12.5–25mg daily
- Water retention, increased appetite, mild glucose elevation
- Optimal for men seeking GH optimization without axis suppression or injection requirement
- Best first-line option for this age group. Oral administration, preserved natural pulsatility, and research-validated safety profile make it the most practical choice
- Exogenous GH
- Direct GH replacement; suppresses endogenous production
- Dependent on dose; typically 100–200% at 2–4 IU daily
- Axis suppression, insulin resistance, joint pain, carpal tunnel
- Reserved for clinically diagnosed GH deficiency; overkill for healthy men with age-related decline
- Not appropriate unless diagnosed deficiency. Higher cost, injection burden, and axis suppression outweigh benefits for men with normal baseline function
- GHRP-2
- Growth hormone releasing peptide; stimulates pituitary GH release
- 60–120% increase per dose; multiple daily injections required
- Hunger spikes, cortisol elevation at higher doses, injection fatigue
- Effective but impractical. Requires 2–3 daily injections and offers no clear advantage over MK-677 for sustained use
- Mechanistically sound but logistically inferior. MK-677's 24-hour half-life eliminates the compliance burden
- CJC-1295 (DAC)
- Long-acting GHRH analog; extends GH pulse duration
- Modest increase (30–50%); sustained elevation over 7–10 days per injection
- Injection site reactions, blunted natural pulsatility, potential desensitization
- Suitable for men seeking less frequent dosing but at cost of natural pulse preservation
- Convenience factor is real, but loss of pulsatile secretion makes it suboptimal for men prioritizing physiological GH patterns